A detailed history of Al Ti Global, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Al Ti Global, Inc. holds 68,535 shares of ABBV stock, worth $12 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
68,535
Previous 57,070 20.09%
Holding current value
$12 Million
Previous $9.79 Billion 38.26%
% of portfolio
0.33%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $1.88 Million - $2.29 Million
11,465 Added 20.09%
68,535 $13.5 Billion
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $3.11 Million - $3.63 Million
-20,074 Reduced 26.02%
57,070 $9.79 Billion
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $8,150 - $9,287
51 Added 0.07%
77,144 $14 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $10.6 Million - $11.9 Million
77,093 New
77,093 $11.9 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.